Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-08

Clinical Trial Update: Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Jelly Fig Extract (Ficus Awkeotsang Makino) for atopic dermatitis has completed. Sponsor: Kaohsiung Veterans General Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jelly Fig Extract (Ficus Awkeotsang Makino extract)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Atopic Dermatitis (AD) | Phase 1 | Status: COMPLETED